Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 31 Issue 1 • January–February 2023

COVID-19 Timeline at NIH (November-December 2022)

COVID-19 Research and Activities at NIH

covid looks like sun

CREDIT: NIAID

Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility in Fort Detrick, Maryland.

November 1: An NIH-funded study finds that blood pressures rose during the pandemic (Hypertension 79:2733–2742, 2022).

November 10: Lawrence Tabak (Performing the Duties of the NIH Director) emails staff with a coronavirus update and warns of a triple threat to public health with influenza, respiratory syncytial virus, and COVID-19 circulating this winter. He reports that NIH will not be pursuing the COVID-19 vaccination requirement for health care workers but urges staff to remain up to date with vaccinations. Tabak reminds staff of NIH guidance on dependent care during duty hours and bringing children onto NIH locations and encourages employees to talk to their supervisors about workplace flexibilities to help balance work and family responsibilities.

November 18: The CDC updates its COVID-19 community levels, moving Phoenix, Arizona, from low to medium. All other NIH locations remain at their current levels.

November 20: NIH scientists speak to National Public Radio about the declining efficacy of monoclonal antibodies against new SARS CoV-2 variants. “Monoclonals had their day, like the Model T or the biplane,” said NIAID’s Carl Dieffenbach, Director of the Division of AIDS and lead of NIH’s Antiviral Program for Pandemics. “Now it’s time to move on.”

November 21: NIAID awards more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

November 22: NIH launches the MakeMyTestCount.org website, developed through NIH’s Rapid Acceleration of Diagnostics Tech program, which allows users to anonymously report the results of any brand of at-home COVID-19 test.

covid green and purple cells

CREDIT: NIAID

Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-CoV-2 virus particles (purple), isolated from a patient sample. Image from the NIAID Integrated Research Facility in Fort Detrick, Maryland.

December 1: The New England Journal of Medicine publishes a perspective by NIAID Director Anthony Fauci reflecting on the perpetual challenge of infectious diseases. (N Engl J Med 387:2009-2011, 2022; DOI:10.1056/NEJMp2213814)

December 2: The CDC updates its COVID-19 community levels. Framingham, Massachusetts, moves from low to medium community level and Detroit, Michigan, moves from medium to low. All other NIH locations remain at their current levels.

December 2: The CDC releases a report that associates the drug Paxlovid (nirmatrelvir plus ritonavir) with decreased hospitalization rates among adults with COVID-19. A second report releases data showing that the bivalent mRNA vaccines provided significant additional protection against symptomatic SARS-CoV-2 infection.

December 8: The FDA amends the emergency use authorizations of the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines to include children down to 6 months of age.

December 9: The CDC updates its COVID-19 community levels. Phoenix, Arizona, moves from medium to high community level. Detroit, Michigan, and Rocky Mountain Laboratories in Hamilton, Montana, move from low to medium.

December 9: Lawrence Tabak (Performing the Duties of the NIH Director) emails staff with a coronavirus update, noting that new COVID-19 cases and hospitalizations are increasing nationally. He brings attention to the FDA’s announcement this week authorizing vaccines for children as young as 6 months, as well as CDC data released on December 2 showing the effectiveness of the antiviral Paxlovid and mRNA bivalent boosters.

December 15: The Journal of Clinical Investigation publishes a paper reporting that NIH scientists found that some cancer and autoimmunity drugs may increase susceptibility to infection by respiratory viruses such as SARS-CoV-2 and influenza A (J Clin Invest 132:e160766, 2022; DOI:10.1172/JCI160766).

December 15-16: The FDA and NIH COVID-19 Scientific Interest Group host a virtual COVID-19 research workshop. Scientists from both agencies deliver talks covering recent findings in COVID-19 virology, immunology, therapeutics, and more.

December 16: In an NIH videocast, NIAID Director Anthony Fauci reflects on his 54-year career at NIH, including having advised seven United States presidents, and his commitment to following the science through outbreaks of infectious diseases, from HIV to Ebola to COVID-19. Videocast (NIH only) at: https://videocast.nih.gov/watch=48728.

December 16: The CDC updates its COVID-19 community levels. Baltimore, Maryland (Bayview Research Center), moves from low to medium community level and Phoenix, Arizona, moves from high to medium. All other NIH locations remain at their current levels.

December 19: NIBIB’s RADx Tech program makes available an early version of a best-practices document for developers that provides recommendations for making at-home COVID-19 diagnostic kits accessible to all users including people with no vision or low vision, a reduced range of dexterity or motor skills, and those who are aging.

December 23: The CDC updates its COVID-19 community levels. Montgomery County, Maryland, moves from low to medium community level and Rocky Mountain Laboratories in Hamilton, Montana, moves from medium to low.

December 30: All NIH locations are at medium in CDC’s COVID-19 community level classification.

This page was last updated on Sunday, January 8, 2023

  • Issue Overview
  • Features
    • Bugs, the Brain, and Behavior
    • Portraits Reflect the Rich Diversity of NIH’s Workforce
    • Harnessing Exposome Data to Predict Disease
    • Toxic Protein and Aging Combine Forces to Drive Brain Disease
    • COVID-19 Timeline at NIH (November-December 2022)
    • Obituaries 2022
  • Departments
    • From the Deputy Director for Intramural Research
    • News Briefs
    • From the Annals of NIH History
    • News You Can Use
    • Colleagues: Recently Tenured
    • Research Briefs
    • The Training Page
    • Photographic Moment
    • Announcements: Kudos
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search